Clinically validated, AI-powered software for personalized screening and early detection of breast cancer.
Mammography and tomosynthesis images have been deidentified and analyzed by Volpara Health.
“Every image we evaluate helps us evolve and improve our software, creating a path toward a healthier future.”
Trusted by Healthcare Leaders
Get ready for 2024
January 1, 2024
New NAPBC Standards
The new NAPBC Standards Manual (2024) is a shift to more personalized care delivery with greater use of risk assessment and preventative protocols.
September 10, 2024
New FDA Density Rule
The Food & Drug Administration has updated the Mammography Quality Standards Act (MQSA) to make patient breast density notification a federal requirement.
Explore events, resources and viewpoints.
24 Oct 2023
AI that Works in Breast Imaging: Volpara literally wrote the eBook!
27 Jun 2023
Volpara is Microsoft’s 2023 Healthcare & Life Sciences Partner of the Year